Core 23 Cord Blood Bank Chooses Mediware’s Transtem Cord Blood Management Software
LENEXA, Kan., Nov. 13, 2013 (GLOBE NEWSWIRE) — Mediware Information Systems, Inc., a provider of comprehensive cellular therapy software applications, announced today that Core 23 BioBank has licensed its Transtem Lab software to automate laboratory operations and simplify the donation process. The Transtem software provides complete process management from online donor registration and account creation through product collection, manufacturing, storage, testing, label generation and release – all within a single Web-based system. Further, automated controls streamline staff workflow, saving time and enhancing quality.
Located in Springfield, MO, Core 23 BioBank offers public and private cord blood donation services while placing emphasis on advancing the science through research and development. As one of the few programs in the Midwest, Core 23 seeks to serve this population and offer families the opportunity to keep their cells close to home. Core 23 will leverage Transtem for a rapid implementation of a cord blood focused electronic data management system within an affordable business model. Implementing the software allows cord blood banks to reduce operating costs by automating processes specific to their cord blood bank workflows.
Michael Perry, Core 23 director of business development, picked the Mediware solution after viewing other solutions. Perry was looking for one product that was adaptable enough to meet his criteria. “There was not another solution out there that was flexible enough to fit all of the needs of cord blood banks”, said Perry. “The Transtem solution was the most complete and comprehensive system we saw. Because we are a new bank, we had the perfect opportunity to implement a system from the start, which allowed us to reduce some of the administration startup costs by using software automation for manual processes that would have required more people to manage.”
The software is unique in that it provides comprehensive capabilities to support cord blood operations with specialized capabilities that span from online donor registration through product collection, preparation, storage, infusion and outcomes reporting. Transtem includes robust laboratory and clinical capabilities which operate as a comprehensive suite that seamlessly integrates donor, product and patient data, managing the full continuum of care.
Information about the Transtem software, including upcoming informational webcasts, can be found on the Mediware website (www.mediware.com).
About Mediware
Mediware delivers interoperable best-of-breed software systems that improve efficiencies and address safety concerns, enabling healthcare organizations to improve care processes while decreasing costs. Core Mediware solutions include blood management technologies for hospitals and blood centers; cell therapy solutions for cord blood banks, cancer treatment centers and research facilities; medication management solutions for hospitals, behavioral health facilities, infusion and specialty pharmacy providers; business intelligence-based performance management solutions for clinical, regulatory and financial aspects of the broader healthcare market; and rehabilitation therapy and respiratory care solutions. For more information about Mediware products and services, visit our website at www.mediware.com.
About Core 23 BioBank
Core 23 BioBank is a hybrid cord blood bank in Springfield, Missouri that combines aspects of both the public and private cord blood banking systems within a 500-mile radius of the bank. The bank provides the Midwest with an easy, safe and secure opportunity to save, or donate, a baby’s umbilical cord blood and cord tissue. As a private cord blood bank, peace-of-mind is provided for families knowing that their baby’s valuable cord blood is safe and secure. As a public cord blood bank, the facilities conduct research specializing in identifying and collecting special and rare tissue types and dedicated to characterization, manufacturing and translational research for transplantation, cell therapies and regenerative medicines. It is the banks’ mission to provide families the opportunity to take part of this new, and proven, modern medicine.
